INS and Hepatic fibrosis: Although our results showed that SW033291 exercises its effects by positively modulating liver metabolic pathways with resolution of insulin resistance and apoptotic activity on parenchymal cells, we did not explicitly test to establish whether this was the mechanism that took place on HSCs for the regression of liver fibrosis.